Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial

Simon Parlow, Pietro Di Santo, Lee H. Sterling, Laura Goodliffe, Pouya Motazedian, Graeme Prosperi‐Porta, Baylie Morgan, Z. Koopman, Richard G. Jung, Melissa Fay Lepage-Ratte, Lisa Robinson, Hannah Feagan, Trevor Simard, George A. Wells, Kwadwo Kyeremanteng, Craig Ainsworth, Faizan Amin, Jeffrey A. Marbach, Shannon M. Fernando, Marino Labinaz, Emilie P. Belley‐Côté, Benjamin Hibbert, Rebecca Mathew